Skip Navigation

Faculty Directory

Gregory de Lissovoy, PhD

Principal Economist, Major Extremity Trauma Research Consortium (METRC)

Associate Professor

- Adjunct

Departmental Affiliation(s):

Health Policy and Management

Contact Information

624 N. Broadway
Hampton House 325
Baltimore , Maryland   21205
US        

410-502-0958

Education

PhD , Univ of North Carolina
MPH , Univ of Alabama

Overview

Dr. de Lissovoy’s primary research interest is the application of cost-effectiveness analysis to the design and improvement of health care delivery systems.  In this capacity he serves as Principal Economist for the Major Extremity Trauma Research Consortium (METRC), a network of approximately 30 clinical centers that has received funding from the Department of Defense to conduct multi-center clinical and economic studies relevant to the treatment and outcomes of orthopedic trauma sustained in the military. 

Honors and Awards

Deputy Editor, Medical Care

cost-effectiveness analysis, health economics, economic analysis alongside clinical trials, medical technology assessment, medical devices

  • Naci H, de Lissovoy G, Hollenbeak C, Custer B, Hofmann A, McClellan W, Gitlin M.  Historical Clinical and Economic Consequences of Anemia Management in Patients with End-Stage Renal Disease on Dialysis Using Erythropoietin Stimulating Agents versus Routine Blood Transfusions: A Retrospective Cost-Effectiveness Analysis.  J Med Econ 2012;15:293-304.

  • Cragin  L, Pan F, Peng S, Zenilman JM, Green J, Doucet C, Chalfin D, de Lissovoy G. Cost-effectiveness of a Fourth-Generation Combination Immunoassay for Human Immunodeficiency Virus (HIV) Antibody and p24 Antigen for the Detection of HIV Infections in the United States. HIV Clin Trials. 2012;13:11-22

  • Turco MA, Cannon LA, Amorosi LS,  Stern S, Stivland T, Underwood P, de Lissovoy G; Kansal A. Economic Modeling of Cost-Effectiveness for New Stent Platform Designs: TAXUS Element (ION) Stent Compared to Bare Metal Express Stent in Small VesselsJ Am Coll Cardiol. 2011;57(14s1):E1185-E1185.

  • de Lissovoy G, Fraeman K, Teerlink JR, Mullahy J, Salon J, Sterz R, Durtschi A, Padley RJ.  Hospital costs for treatment of acute heart failure: Economic analysis of the REVIVE II Study.  Eur J Health Econ.  2010:11:185-193

  • de Lissovoy G, Hutchins V, Murphy D, Song D, Fraeman K, Vaughn B. Surgical site infection: incidence and impact on hospital utilization and treatment costs.  Am J Infect Control. 2009:37:387-97.